Organogenesis is a peer-reviewed journal, available in print and online, that publishes significant advances on all aspects of organ development. The journal covers organogenesis in all multi-cellular organisms and also includes research into tissue engineering, artificial organs and organ substitutes.
The overriding criteria for publication in Organogenesis are originality, scientific merit and general interest. The audience of the journal consists primarily of researchers and advanced students of anatomy, developmental biology and tissue engineering.
The emphasis of the journal is on experimental papers (full-length and brief communications), but it will also publish reviews, hypotheses and commentaries. The Editors encourage the submission of addenda, which are essentially auto-commentaries on significant research recently published elsewhere with additional insights, new interpretations or speculations on a relevant topic. If you have interesting data or an original hypothesis about organ development or artificial organs, please send a pre-submission inquiry to the Editor-in-Chief. You will normally receive a reply within days. All manuscripts will be subjected to peer review, and accepted manuscripts will be posted to the electronic site of the journal immediately and will appear in print at the earliest opportunity thereafter.
《Organogenesis》是一本由TAYLOR & FRANCIS INC出版商出版的專業醫學期刊,該刊創刊于2004年,刊期4 issues/year,該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中,該刊分區信息為大類學科:工程技術 3區,小類學科:生化與分子生物學 4區;發育生物學 4區;工程:生物醫學 4區;在JCR(Journal Citation Reports)分區等級為Q3。該刊發文范圍涵蓋生化與分子生物學等領域,旨在及時、準確、全面地報道國內外生化與分子生物學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等,促進學術交流,鼓勵學術創新。2021年影響因子為2.316,平均審稿速度>12周,或約稿。
大類學科 | 分區 | 小類學科 | 分區 | Top期刊 | 綜述期刊 |
工程技術 | 4區 | BIOCHEMISTRY & MOLECULAR BIOLOGY 生化與分子生物學 DEVELOPMENTAL BIOLOGY 發育生物學 ENGINEERING, BIOMEDICAL 工程:生物醫學 | 4區 4區 4區 | 否 | 否 |
JCR分區等級 | JCR所屬學科 | 分區 | 影響因子 |
Q3 | ENGINEERING, BIOMEDICAL | Q3 | 2.316 |
DEVELOPMENTAL BIOLOGY | Q3 | ||
BIOCHEMISTRY & MOLECULAR BIOLOGY | Q4 |
影響因子 | h-index | Gold OA文章占比 | 研究類文章占比 | OA開放訪問 | 平均審稿速度 |
2.316 | 41 | 12.90% | 66.67% | 未開放 | >12周,或約稿 |